Table 1.
Demographics at time of biopsy of patients with CKD or healthy living donors for which FAR2 glomerular gene expression was assessed
| Disease Diagnosis or Living Donor Status | Samples, n | Sex | eGFR, ml/min/1.73 m2 | Age, yr |
|---|---|---|---|---|
| Diabetic nephropathy | 12 | 8 M/4 W | 52.9 ± 30.5 | 54.3 ± 11.0 |
| Focal segmental glomerulosclerosis | 24 | 12 M/12 W | 74.8 ± 34.0 | 45.1 ± 15.5 |
| IgA nephropathy | 27 | 19 M/8 W | 73.9 ± 37.1 | 35.9 ± 14.1 |
| Minimal change disease | 14 | 8 M/ 6 W | 97.5 ± 45.8 | 36.8 ± 17.7 |
| Membranous glomerulonephropathy | 21 | 12 M/9 W | 84.8 ± 40.2 | 53.3 ± 17.9 |
| Lupus nephritis | 32 | 7 M/25 W | 63.7 ± 29.4 | 34.7 ± 13.3 |
| Healthy living donors | 31 | 16 M/15 W | 106.7 ± 29.4 | 48.0 ± 11.6 |
Values are reported as means ± SD for estimated glomerular filtration rate (eGFR) and age. CKD, chronic kidney disease; M, man; W, woman.